These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8447233)

  • 21. Complement activation in neonatal disease.
    Zilow EP
    Eur J Pediatr; 1993 May; 152(5):459-60. PubMed ID: 8319722
    [No Abstract]   [Full Text] [Related]  

  • 22. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma.
    Krug N; Tschernig T; Erpenbeck VJ; Hohlfeld JM; Köhl J
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1841-3. PubMed ID: 11734433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary injury induced by C3a and C5a anaphylatoxins.
    Stimler NP; Hugli TE; Bloor CM
    Am J Pathol; 1980 Aug; 100(2):327-48. PubMed ID: 6967702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic treatment and complement activation.
    Agostoni A; Gardinali M; Frangi D; Cugno M; Cafaro C; Conciato L; Sponzilli C; Salmoirago E
    Ann Ital Med Int; 1994; 9(3):178-9. PubMed ID: 7946896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in systemic complement component 3a and 5a levels in patients with cerebral arteriovenous malformations.
    Haque R; Hwang BY; Appelboom G; Piazza MA; Guo K; Connolly ES
    J Clin Neurosci; 2011 Sep; 18(9):1235-9. PubMed ID: 21742500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of complement activation during membrane-based plasmapheresis procedures.
    Burnouf T; Eber M; Kientz D; Cazenave JP; Burkhardt T
    J Clin Apher; 2004; 19(3):142-7. PubMed ID: 15493055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Correlation of anaphylatoxin levels and survival with bacteremia and endotoxemia in the first 2 hours after trauma.
    Redan JA; Flanagan JJ; Rush BF; Machiedo GW; Lysz TW; Murphy TF
    Curr Surg; 1990; 47(1):30-2. PubMed ID: 2311424
    [No Abstract]   [Full Text] [Related]  

  • 29. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of three separate anaphylatoxins from complement-activated human serum.
    Hugli TE; Gerard C; Kawahara M; Scheetz ME; Barton R; Briggs S; Koppel G; Russell S
    Mol Cell Biochem; 1981 Dec; 41():59-66. PubMed ID: 6977086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re-evaluation of the storage conditions for blood samples which are used for determination of complement activation.
    Stöve S; Klos A; Bautsch W; Köhl J
    J Immunol Methods; 1995 May; 182(1):1-5. PubMed ID: 7769237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Isolated hyperthermic liver perfusion with cytostatic-containing perfusate activates the complement cascade.
    Arnestad JP; Bengtsson A; Bengtson JP; Henriksson BA; Stenqvist O; Naredi P; Hafström L
    Br J Surg; 1992 Sep; 79(9):948-51. PubMed ID: 1422767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human plasmacytoid dendritic cells express receptors for anaphylatoxins C3a and C5a and are chemoattracted to C3a and C5a.
    Gutzmer R; Köther B; Zwirner J; Dijkstra D; Purwar R; Wittmann M; Werfel T
    J Invest Dermatol; 2006 Nov; 126(11):2422-9. PubMed ID: 16778800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement system activation during orthotopic liver transplantation in man. Indications of peroperative complement system activation in the gut.
    Rønholm E; Tomasdottir H; Runeborg J; Bengtsson A; Bengtson JP; Stenqvist O; Friman S
    Transplantation; 1994 Jun; 57(11):1594-7. PubMed ID: 8009593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement activation during storage of whole blood, red cells, plasma, and buffy coat.
    Hyllner M; Arnestad JP; Bengtson JP; Rydberg L; Bengtsson A
    Transfusion; 1997 Mar; 37(3):264-8. PubMed ID: 9122898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of anaphylatoxins C3a, C4a and C5a in the scales of psoriasis and inflammatory pustular dermatoses.
    Takematsu H; Ohkohchi K; Tagami H
    Br J Dermatol; 1986 Jan; 114(1):1-6. PubMed ID: 3484631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement-derived anaphylatoxins in human donor corneas treated with excimer laser.
    Gardner BP; Pleyer U; Mondino BJ; Sumner HL; Frieberg ML; Imperia PS
    Ophthalmic Surg Lasers; 1995; 26(6):568-71. PubMed ID: 8746579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generation of human C3a, C4a, and C5a anaphylatoxins by protein A of Staphylococcus aureus and immobilized protein A reagents used in serotherapy of cancer.
    Langone JJ; Das C; Bennett D; Terman DS
    J Immunol; 1984 Aug; 133(2):1057-63. PubMed ID: 6610702
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.